| Detected | Trial | Change |
|---|---|---|
| 2026-08-02 | NCT06519110 Neratinib Tablets Monotherapy for Advanced Solid Tumors With HER2 Mutations |
overall status: Not Yet Recruiting → Unknown |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 2 | |||
| NCT06183736 | CVL237 Tablets in the Treatment of Advanced Solid Tumors With PTEN Deficiency | Advanced Solid Tumors | Not Yet Recruiting |
| NCT06374888 | Nilatinib Maleate Tablets Combined With Capecitabine in the Treatment of HER2-positive… | Her2-positive Advanced Esophageal/Esophagogastric Junction/Gastric Adenocarcinoma With Brain Metastasis | Not Yet Recruiting |
| NCT07446049 | A Single-arm, Open-label, Multicenter, Phase Ib/II Clinical Trial of CVL237 Tablets in… | Locally Advanced or Metastatic Solid Tumors | Not Yet Recruiting |
| Phase 1/2 | |||
| NCT07157956 | CVL006 Combination Therapy in Advanced Solid Tumors | Advanced Solid Tumor | Not Yet Recruiting |
| NCT07615660 | Clinical Study of CVL006 Combination With 9MW2821 | Advanced Solid Tumor | Not Yet Recruiting |
| Phase 1 | |||
| NCT06621615 | Clinical Study of CVL006 Injection in Advanced Solid Tumors | Advanced Solid Tumor | Not Yet Recruiting |